# Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

> **NCT00309530** · PHASE3 · COMPLETED · sponsor: **Austrian Breast & Colorectal Cancer Study Group** · enrollment: 598 (—)

## Conditions studied

- Colon Cancer Stage III

## Interventions

- **DRUG:** 5-fluorouracil, levamisol, interferon

## Key facts

- **NCT ID:** NCT00309530
- **Lead sponsor:** Austrian Breast & Colorectal Cancer Study Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1990-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 598 (—)
- **Last updated:** 2006-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309530, "Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00309530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*